» Articles » PMID: 36691924

Evolution and Emergence of Primate-specific Interferon Regulatory Factor 9

Overview
Journal J Med Virol
Specialty Microbiology
Date 2023 Jan 24
PMID 36691924
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of interferon (IFN) to its receptors leads to formation of IFN-stimulated gene factor 3 (ISGF3) complex that activates the transcription of cellular IFN-regulated genes. IFN regulatory factor 9 (IRF9, also called ISGF3γ or p48) is a key component of ISGF3. However, there is limited knowledge regarding the molecular evolution of IRF9 among vertebrates. In this study, we have identified the existence of the IRF9 gene in cartilaginous fish (sharks). Among primates, several isoforms unique to old world moneys and great apes are identified. These IRF9 isoforms are named as primate-specific IRF9 (PS-IRF9) to distinguish from canonical IRF9. PS-IRF9 originates from a unique exon usage and differential splicing in the IRF9 gene. Although the N-terminus are identical for all IRF9s, the C-terminal regions of the PS-IRF9 are completely different from canonical IRF9. In humans, two PS-IRF9s are identified and their RNA transcripts were detected in human primary peripheral blood mononuclear cells. In addition, human PS-IRF9 proteins were detected in human cell lines. Sharing the N-terminal exons with the canonical IRF9 proteins, PS-IRF9 is predicted to bind to the same DNA sequences as the canonical IRF9 proteins. As the C-terminal regions of IRFs are the determinants of IRF functions, PS-IRF9 may offer unique biological functions and represent a novel signaling molecule involved in the regulation of the IFN pathway in a primate-specific manner.

Citing Articles

Cytoplasmic Shift of Interferon Regulatory Factors Co-Evolved With Jawed Vertebrate Innate Immunity.

Hubing V, Marquis A, Ziemann C, Moriyama H, Moriyama E, Zhang L J Med Virol. 2025; 97(2):e70247.

PMID: 39977406 PMC: 11841930. DOI: 10.1002/jmv.70247.


Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets-Recent Insights at Molecular and Cellular Level.

Poller W, Sahoo S, Hajjar R, Landmesser U, Krichevsky A Cells. 2023; 12(22).

PMID: 37998395 PMC: 10670380. DOI: 10.3390/cells12222660.


Evolution and emergence of primate-specific interferon regulatory factor 9.

Drury S, Claussen G, Zetterman A, Moriyama H, Moriyama E, Zhang L J Med Virol. 2023; 95(2):e28521.

PMID: 36691924 PMC: 10107944. DOI: 10.1002/jmv.28521.

References
1.
Du K, Zhong Z, Fang C, Dai W, Shen Y, Gan X . Ancient duplications and functional divergence in the interferon regulatory factors of vertebrates provide insights into the evolution of vertebrate immune systems. Dev Comp Immunol. 2017; 81:324-333. DOI: 10.1016/j.dci.2017.12.016. View

2.
Fu X, Kessler D, Veals S, Levy D, Darnell Jr J . ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A. 1990; 87(21):8555-9. PMC: 54995. DOI: 10.1073/pnas.87.21.8555. View

3.
Horvath C, Stark G, Kerr I, Darnell Jr J . Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex. Mol Cell Biol. 1996; 16(12):6957-64. PMC: 231699. DOI: 10.1128/MCB.16.12.6957. View

4.
Luker K, Pica C, Schreiber R, Piwnica-Worms D . Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Res. 2001; 61(17):6540-7. View

5.
Huber M, Suprunenko T, Ashhurst T, Marbach F, Raifer H, Wolff S . IRF9 Prevents CD8 T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection. J Virol. 2017; 91(22). PMC: 5660491. DOI: 10.1128/JVI.01219-17. View